Edges in Network
| Network | GSE25065_egf1520 - GSE25065 - SiGN-BN HC+Bootstrap |
| Network Description | Validation cohort for genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer |
| Node | BCL2L13 |
| Upstream (Parents) |
|---|
| (<<) BAD → BCL2L13 |
| (<<) CD3EAP → BCL2L13 |
| (<<) CDK5 → BCL2L13 |
| (<<) CRNN → BCL2L13 |
| (<<) DEAF1 → BCL2L13 |
| (<<) DNAJA4 → BCL2L13 |
| (<<) DNM3 → BCL2L13 |
| (<<) E2F6 → BCL2L13 |
| (<<) FUT1 → BCL2L13 |
| (<<) INVS → BCL2L13 |
| (<<) IVL → BCL2L13 |
| (<<) JUND → BCL2L13 |
| (<<) KHDRBS1 → BCL2L13 |
| (<<) KLK5 → BCL2L13 |
| (<<) KLK8 → BCL2L13 |
| (<<) MAPK1 → BCL2L13 |
| (<<) PIK3C3 → BCL2L13 |
| (<<) PIK3R5 → BCL2L13 |
| (<<) PITPNA → BCL2L13 |
| (<<) PLAUR → BCL2L13 |
| (<<) PLD2 → BCL2L13 |
| (<<) PNO1 → BCL2L13 |
| (<<) POLR1B → BCL2L13 |
| (<<) PRKCD → BCL2L13 |
| (<<) PRKCQ → BCL2L13 |
| (<<) RAD51L3 → BCL2L13 |
| (<<) RHOQ → BCL2L13 |
| (<<) RNF111 → BCL2L13 |
| (<<) RPS6KA3 → BCL2L13 |
| (<<) S100A2 → BCL2L13 |
| (<<) SF3A2 → BCL2L13 |
| Downstream (Children) |
|---|
| BCL2L13 → CBL (>>) |
| BCL2L13 → CHST12 (>>) |
| BCL2L13 → CTRB2 (>>) |
| BCL2L13 → FGFR2 (>>) |
| BCL2L13 → FZD1 (>>) |
| BCL2L13 → FZD8 (>>) |
| BCL2L13 → GALK1 (>>) |
| BCL2L13 → GLTPD1 (>>) |
| BCL2L13 → HIPK1 (>>) |
| BCL2L13 → HLA-DOA (>>) |
| BCL2L13 → IL1F7 (>>) |
| BCL2L13 → MAPK12 (>>) |
| BCL2L13 → MT3 (>>) |
| BCL2L13 → NPC1 (>>) |
| BCL2L13 → PDE4C (>>) |
| BCL2L13 → PLA2G3 (>>) |
| BCL2L13 → RAF1 (>>) |
| BCL2L13 → RPS14 (>>) |
| BCL2L13 → RPS6KA4 (>>) |
| BCL2L13 → SLC6A14 (>>) |
| BCL2L13 → SPINK1 (>>) |
| BCL2L13 → STX12 (>>) |
| BCL2L13 → UBE2D4 (>>) |
| BCL2L13 → ZNF215 (>>) |
